| Literature DB >> 31993226 |
Ehsan Aghaei Moghadam1,2, Leila Hamzehlou2, Bobak Moazzami2, Mina Mehri2, Vahid Ziaee1,2,3.
Abstract
OBJECTIVES: Coronary artery (CA) involvement is the most well known complication of Kawasaki disease (KD). Previous studies have suggested that QT dispersion has a predictive value in diagnosing cardiac ischemia, ventricular arrhythmia, and sudden cardiac death. However, limited data exits regarding the application of QT dispersion in KD. Therefore, we sought to determine whether there is a relationship between QT dispersion and CA involvement in patients with KD.Entities:
Keywords: Aneurysm; Electrocardiography; Kawasaki Disease
Year: 2020 PMID: 31993226 PMCID: PMC6975257 DOI: 10.5001/omj.2020.06
Source DB: PubMed Journal: Oman Med J ISSN: 1999-768X
Clinical characteristics and comparison between patients with and without coronary artery involvement.
| Parameters | Total | With coronary involvement | Without coronary involvement | |
|---|---|---|---|---|
| Age, months | 21.0 (11.0–48.0) | 15.0 (6.5–48.0) | 30.0 (18.0–50.0) | 0.020 |
| Sex | 0.036 | |||
| Male, n (%) | 43 (61.4) | 27 (73.0) | 16 (48.5) | |
| Female, n (%) | 27 (38.6) | 10 (27.0) | 17 (51.5) | |
| Platelet count, × 103 µL | 560.0 (417.0–722.0) | 653.0 (494.0–1010.0) | 458.0 (376.0–601.0) | 0.001 |
| CRP | 61.0 (34.0–130.0) | 68.0 (36.0–145.0) | 53.0 (33.0–118.0) | 0.458 |
| ESR | 80.5 (54.2–102.7) | 76.0 (52.1–104.5) | 81.0 (58.5–103.5) | 0.791 |
| QTc dispersion, ms | ||||
| Acute phase | 78.5 (60.7–115.0) | 108.0 (89.5–138.5) | 63.0 (54.0–74.5) | 0.001 |
| Convalescence phase | 64.0 (49.7–141.2) | 139.0 (74.5–209.0) | 50.0 (43.0–63.0) | 0.001 |
Data presented as interquartile range with 25th and 75th percentiles.
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; QTc: corrected QT.
p-values < 0.050 were considered significant.
*The between-group comparison was made using Mann–Whitney’s U test.
Figure 1Association between QTc dispersion in the acute phase and CA involvement based on gender. The boxes represent the interquartile range, with the upper and lower edges of the boxes representing the 75th and 25th percentiles, respectively. The central horizontal lines within the boxes represent the median levels for each group.
Figure 2Association between QTc dispersion in the convalescence phase and CA involvement based on gender. The boxes represent the interquartile range, with the upper and lower edges of the boxes representing the 75th and 25th percentiles, respectively. The central horizontal lines within the boxes represent the median levels for each group.
Correlation between corrected QT dispersion (acute phase) and clinical and laboratory parameters.
| Parameters | ||
|---|---|---|
| Age | 0.170 | 0.160 |
| Gender | -0.319 | 0.007* |
| Platelet | 0.160 | 0.186 |
| CRP | 0.099 | 0.414 |
| ESR | -0.087 | 0.472 |
| Coronary artery involvement | 0.591 | < 0.001* |
* Statistically significant.
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.
Correlation between corrected QT dispersion (convalescence phase) and clinical and laboratory parameters.
| Parameters | ||
|---|---|---|
| Age | -0.195 | 0.106 |
| Gender | -0.335 | 0.005 |
| Platelet | 0.176 | 0.144 |
| CRP | -0.009 | 0.944 |
| ESR | -0.094 | 0.440 |
| Coronary artery involvement | 0.669 | < 0.001 |
* Statistically significant.
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.
Figure 3ROC analysis was performed to calculate the AUC, sensitivity, and specificity of the QTc dispersion in the acute phase. The optimal cut-off value for QTc dispersion was 76.5 ms (sensitivity = 83.8% and specificity = 80.1%).
Figure 4ROC analysis was performed to calculate the AUC, sensitivity, and specificity of the QTc dispersion in the convalescence phase. The optimal cut-off value for QTc dispersion was 63.5 ms (sensitivity = 83.8% and specificity = 85.2%).